CID 135566112

Acetildenafil

Structural Information

Molecular Formula
C25H34N6O3
SMILES
CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)C(=O)CN4CCN(CC4)CC)OCC)C
InChI
InChI=1S/C25H34N6O3/c1-5-8-19-22-23(29(4)28-19)25(33)27-24(26-22)18-15-17(9-10-21(18)34-7-3)20(32)16-31-13-11-30(6-2)12-14-31/h9-10,15H,5-8,11-14,16H2,1-4H3,(H,26,27,33)
InChIKey
RRBRQNALHKQCAI-UHFFFAOYSA-N
Compound name
5-[2-ethoxy-5-[2-(4-ethylpiperazin-1-yl)acetyl]phenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

6083
References

223
Patents

466.26923 Da
Monoisotopic Mass

2.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 467.27651 220.5
[M+Na]+ 489.25845 227.9
[M-H]- 465.26195 222.2
[M+NH4]+ 484.30305 222.6
[M+K]+ 505.23239 219.7
[M+H-H2O]+ 449.26649 207.4
[M+HCOO]- 511.26743 229.7
[M+CH3COO]- 525.28308 236.8
[M+Na-2H]- 487.24390 216.2
[M]+ 466.26868 223.1
[M]- 466.26978 223.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe